ASH: Adding Subcutaneous Daratumumab Slows Advanced Multiple Myeloma
TUESDAY, Dec. 8, 2020 — For patients with relapsed/refractory multiple myeloma (RRMM), subcutaneous daratumumab plus pomalidomide and dexamethasone (D-Pd) reduces
Read more
Adding belimumab improves renal outcome in lupus nephritis
(HealthDay)—The addition of belimumab versus placebo to standard therapy increases the likelihood of a primary efficacy renal response in patients
Read more
Adding social workers to care teams can cut hospital admissions for veterans
(HealthDay)—An initiative to add social workers to rural primary care teams increases social work encounters among veterans and reduces hospital
Read more